Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual practice, women's uptake of chemoprevention has been poor. We explored factors that influence acceptability, adherence, and dropout in the International Breast (Prevention) Intervention Study during our first 3 years of activity at the Modena Familial Breast and Ovarian Cancer Center. We evaluated socio-demographic characteristics, health status, adherence, and side effect intensity. Semi-structured interviews analyzed reasons for accepting/refusing/stopping the trial. A total of 471 postmenopausal women were invited to participate, of which 319 declined to participate (68%), 137 accepted to participate (29%), and 15 participants did not make a...
OBJECTIVES: Only 1.2%-11% of all potential study participants participate in cancer studies. Low par...
Guidelines endorse the use of chemoprevention for breast cancer risk reduction. This study examined ...
Objectives: 1) To describe how women at high-risk for breast cancer (BC) perceive their at-risk stat...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
There is significant interest in developing chemoprevention trials for women at high risk for breast...
Objective: The purpose of this study was to test the effect of patient involvement levels, developed...
Disclosures: The authors indicated no financial relationships. Purpose. Although breast cancer is a ...
This paper reports on the reasons why patients agreed to or declined entry into randomized trials of...
Few studies have explored factors related to participation in cancer chemoprevention trials. The pur...
Why, given similar medical circumstances - high familial risk of breast cancer - will some women ele...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
Why, given similar medical circumstances—high familial risk of breast cancer—will some women elect t...
Background: Chemoprevention for women at elevated risk of breast cancer is endorsed by international...
Only 1.2%–11% of all potential study participants participate in cancer studies. Low participation r...
OBJECTIVES: Only 1.2%-11% of all potential study participants participate in cancer studies. Low par...
Guidelines endorse the use of chemoprevention for breast cancer risk reduction. This study examined ...
Objectives: 1) To describe how women at high-risk for breast cancer (BC) perceive their at-risk stat...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
Chemoprevention for women at risk for breast cancer has been shown to be effective, but in actual pr...
There is significant interest in developing chemoprevention trials for women at high risk for breast...
Objective: The purpose of this study was to test the effect of patient involvement levels, developed...
Disclosures: The authors indicated no financial relationships. Purpose. Although breast cancer is a ...
This paper reports on the reasons why patients agreed to or declined entry into randomized trials of...
Few studies have explored factors related to participation in cancer chemoprevention trials. The pur...
Why, given similar medical circumstances - high familial risk of breast cancer - will some women ele...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
Why, given similar medical circumstances—high familial risk of breast cancer—will some women elect t...
Background: Chemoprevention for women at elevated risk of breast cancer is endorsed by international...
Only 1.2%–11% of all potential study participants participate in cancer studies. Low participation r...
OBJECTIVES: Only 1.2%-11% of all potential study participants participate in cancer studies. Low par...
Guidelines endorse the use of chemoprevention for breast cancer risk reduction. This study examined ...
Objectives: 1) To describe how women at high-risk for breast cancer (BC) perceive their at-risk stat...